Summary.-A method is presented for the description of a heterogeneous cell population with respect to the volume and density of its cellular components, based on computer analysis of the cell-volume spectra of density-gradient fractions. Display programmes were developed to produce either a perspective plot or an isofrequency contour plot ("fingerprint") of the two-parameter data. The use of sequential density and velocity gradients permitted the separation and study of the properties of any subpopulation.
Summary.-A method is presented for the description of a heterogeneous cell population with respect to the volume and density of its cellular components, based on computer analysis of the cell-volume spectra of density-gradient fractions. Display programmes were developed to produce either a perspective plot or an isofrequency contour plot ("fingerprint") of the two-parameter data. The use of sequential density and velocity gradients permitted the separation and study of the properties of any subpopulation.
We describe the results of an analysis of cellular heterogeneity in an ovarian carcinoma cell line and in 2 cases of ascites cells from human ovarian carcinoma The proliferative state (labelling index) and growth potential (culture clonogenicity) of cells from one malignant ascites have been "mapped" in terms of density/volume parameters. The results are discussed in terms of their impact on the view of human ovarian carcinoma as a stem-cell system. THE STEM-CELL MODEL of tumour growth predicts heterogeneity because of cellular differentiation within human neoplasms (Mackillop et al., in press: Pierce et al., 1978) . We have recently investigated the morphological and functional heterogeneity in human ovarian carcinoma, using density-gradient centrifugation (Mackillop & Buick, in press: Buick & Mackillop, 1981) . We have defined two broad functional subpopulations of neoplastic cells within continuous cell-density profiles. The first consisted of small, high-density cells, with histochemical staining characteristics similar to the normal cells of the superficial epithelium of the ovary. These were not proliferative in the malignant ascites nor did they form colonies in agar culture. The second subpopulation consisted of large, less differentiated cells, many of them proliferative. A small subgroup of these cells was able to form colonies in soft agar. Density-gradient centrifugation alone was unable to separate these cells from the remainder of the large, low-density population (Buick & Mackillop, 1981) .
In an attempt to refine our understanding of the cellular composition of human neoplasms, we have developed the technology to analyse heterogenous cell populations with respect to volume and density. We present here methodology which allows the description and preparation of a cell population in terms of the volume and density of its cellular components. We believe that the detailed study of the morphological and proliferative characteristics of these well defined sub-populations will add to our understanding of the cellular composition of human neoplasms, and may also be applicable to the study of normal tissues.
Our methodology was evolved using a human ovarian tumour-cell line (Buick & Trent, in preparation) which allowed us to define the degree of volume/density heterogeneity to be expected on the basis of cell-cycle variation alone in an otherwise homogeneous population. We subsequently studied specimens of ascites from two patients with ovarian carcinoma. They were selected from a larger series on the basis of their high percentage of tumour cells, which allowed the description of the heterogeneity within the neoplastic cell population without the problem of the non-neoplastic elements always present in cell suspensions derived from solid tumours.
Sedimentation and volume analyses of cell populations have been applied in the past to normal and neoplastic haemopoietic tissues (Miller, 1973) . The method described is conceptually different, in that it is based on the volume analysis of cell fractions prepared on a density gradient, and in practical terms the resolution with respect to density is greater. In this regard it is similar to the combined density-gradient centrifugation and centrifugal elutriation used by Grdina et al. (1977) Density gradient8.-Discontinuous gradients of bovine serum albumin were prepared as described previously (Buick & Mackillop, 1981;  Mackillop & Buick, in press) . Briefly, the cell suspensions (2x 107 cells/gradient) were layered on to discontinuous gradients (11 ml) constructed manually (11 x 1 ml) and centrifuged to equilibrium (600 g for 30 min). The cells banded at the interphases, and the fractions were collected from the top, using a Pasteur pipette. Fraction 12 contained pelleted cells. Recovery was consistently >95%, and viability of the cells was not compromised. Velocity gradient8.-A modification of the procedure of Miller & Phillips (1969) was applied. About 107 cells from individual density fractions (pooled from multiple identical density gradients) were layered on top of linear gradients of 5-15% FCS (prepared in 50ml siliconized glass tubes). Cells were allowed to sediment under gravity for 3 h at 4°C, by which time 8 x 6-5ml fractions were collected from the top by pipette.
Cells were harvested by centrifugation, counted in a haemacytometer and analysed for volume as described below. Due to the high viability and lack of cell clumps in these preparations. the cell counts performed by haemacytometer and by Coulter counter were in close agreement. Cell recovery was > 90%o and cell viability was not compromised.
Combined density/volume analysis-Cellvolume measurements on individual density or velocity sedimentation fractions were made with an electronic cell sizer, consisting of a 140jum Coulter volume orifice (Coulter Electronics, Hialeah, Florida) connected to custom signal-processing electronics (Miller, 1973) . The cell-volume data were collected with a Nuclear Data (Schaumberg, Illinois) ND1200 Pulse Height analyser, and later transferred to a PDP 11/10 minicomputer (Digital Equipment Corporation, Maynard, Massachusetts) connected to a Tektronix Model 4662 Plotter (Beaverton, Oregon).
The necessary programmes have been developed to process and display the density/volume information. A primary programme normalizes the cell-volume data of each gradient fraction, weights the volume data in each fraction by the cell number in its fraction and stores the data as an array of 1536 data points (12 density fractions. each containing 128 cell-volume data points).
Two display programmes have been developed. The first plots the two-parameter data in a perspective view, overlaid with a logarithmic grid on the Y axis and incorporating hidden-line suppression. This programme produces a plot with logarithmic cell-volume information on the Y axis, cell-density data on the X axis, and cell number as the height (e.g. Fig. 3 ).
The second display programme generates isofrequency contour representations of the two-parameter data. Each of the 1536 data points is assigned a value between "0" and "10", depending upon its height relative to the modal datum. The mode would be assigned a value of "10", the datum values between 90 and 100% of the mode would be assigned to a range of "9", etc. All data points corresponding to like ranges are then plotted on the Tektronix plotter, with logarithmic spacing for cell volume, using unique symbols for each range. The boundaries of these unique symbols are joined by hand to produce the isofrequency contours of the two-parameter data.
Curve fitting.-Although for the cell line, and for certain tumour specimens, the basic method described above produces acceptable data, we encountered two problems wAhich initially restricted the usefulness of the method. Firstly, the small-volume end of the frequency distribution is contaminated by instrument noise. Secondly, tumour-cell suspensions always contain small-volume debris which adds to the distortion at the lower end of the spectrum. When the modal tumourcell volume is high, no major problem is encountered in analysing the data, as the volume peak lies far to the right of the electronic noise and low-volume debris. More commonly, however, the modal cell volume lies within the range where significant artefact is present. In these cases, curvefitting techniques have been used to elucidate the meaning of the cell-volume data. The cell-volume histogram is fitted to its own log-normal distribution by a computer adaptation (Stewart, 1979 ) of the probit analysis described by Finney (1962) . The fitting programme analyses each volume spectrum individually, while excluding the extreme ends (corresponding to very low and very high cell "volumes") where the data are unlikely have to come from intact, viable cells. This method significantly reduces the effect of artefact in the lowvolume range.
Labelling index (LI).-Cell suispensions were washed twice in phosphate-buffered saline (PBS), resuspended at 106/ml in a medium without nucleosides + 5 [Ci/ml [3H]-dT (sp. act., 65 Ci/mol) and incubated at 37°C for 1 h. The cells were then washed x 3 in PBS, and cytocentrifuge preparations made. After fixation (95% ethanol, 2 min) the slides were dipped in Kodak NTB3 emulsion (1:1 with distilled H20). After exposure for 48 h the slides were developed using standard Kodak reagents and stained with Wright's stain (0.3% in methanol for 4 min) and Giemsa (4% for 6 min). Cells displaying > 10 grains over the nucleus were termed positive.
Assessment of clonogenicity in agar.-Assessment of agar clonogenicity was based on microwell culture (104 cells/0 1 ml culture/ well) as described previously (Buick & Fry, 1980) . The enrichments of Hamburger et al. (1978) were used, but without conditioned medium. After 10-14 days' incubation at 37°C in a humidified atmosphere of C02 cells in log phase appear in the higherdensity bands. Preliminary experiments indicate that these cells do not have more DNA/cell than the bulk of the cells. Fig.  2a shows the volume distribution of the cell line in stationary and log phase on a linear scale. Replotting on a log scale (Fig. 2b) reveals that the stationary-phase cells have a log-normal distribution. We assume that these non-cycling cells are arrested in prolonged G1 or G2 phase. The log-phase population has a greater modal volume. Fig. 3 Sequential equilibrium-density centrifugation and velocity-sedimentation were applied to the cells of Patient 1, described in Fig. 4 A & Buick, in press ). These individual iso-density cell populations were fractionated by velocity sedimentation at unit gravity (as described in Methods) and sizing of the resultant fractions was performed electronically. Fig. 5 shows an example of the size distribution of fractions derived from velocity sedimentation. Velocity sedimentation fractions 3, 5 and 8 from density cut 5 are shown. By comparing the modal volume of a given velocitysedimentation fraction and the volumes 535 described by programme 1 in Fig. 4B for density fraction 5, it is possible to ascertain the position of such cells in the twodimensional representation of the volume/ density parameters. Any cell fraction prepared in this manner can be successfully "mapped" on the isocontour representation of the total cell population. Finer resolution could be achieved by increasing the number of preparative fractions in either dimension; i.e. > 12 density cuts or > 8 sedimentation-velocity fractions. Thus, in this case, the sedimentationvelocity fractions from each of the three chosen density fractions (5, 6, 7) were "mapped" on to the isocontour representation. Velocity-gradient fractions 1 and 2 from density cut 5, and fraction 1 from density cut 6, did not contain sufficient cells for the mapping procedure. In parallel, cells from the fractions were assessed for labelling index and agar clonogenicity. The result of superimposing these data (as percentages of maximum LI or clonogenicity) on the isocontour "map" of Fig. 4 , is shown in Fig. 6 Fig. 4B ). The basic analytical procedure was readily applicable to tumour-cell suspensions derived from malignant effusions (Fig. 4) . The data from 2 such cases show greater heterogeneity than in the cellline data. Any significance of patient-topatient variation in cell distribution in the density/volume "map" must await a study of more patients. We initially encountered problems in some cases, due to artefact in the low-volume range. This has been overcome by devising a curvefitting procedure which assumes lognormality for the volume of individual density fractions. Our experience indicates that most patient material will require such procedures.
The method of cell separation by sequential density and velocity-gradient sedimentation allows us to prepare any cellular subpopulation of specific volume/ density characteristic and to study its properties. Through electronic volume determination of such separated populations it is possible to "map" them on the isofrequency contours of the total tumourcell population. As an example, Fig. 6 demonstrates the position (in terms of volume/density characteristics) of the cells capable of incorporating [3H]dT and those capable of agar clonogenicity for Patient 1 (Fig. 4B) . The clonogenic population appears as a subpopulation of the proliferative cells, as predicted by the stem-cell model of tumour growth (Mackillop et al., in press ). Mixing experiments (Table) indicated that the clono genicity measurements did assess an intrinsic cellular property, and were not influence by growth-inhibitory factors in certain fractions. A corollary of the refinement in cell fractionation was that plating efficiency of the tumour cells in agar was considerably higher than previously reported. The peak fraction (for clonogenicity) demonstrated 148 colonies/ 104 cells plated, withich represents an enrichment of about 20-fold over unfractionated cells. The density characteristics of proliferative cells and clonogenic cells are very similar in different patients (Mackillop & Buick, in press) . A similar identity of volume characteristics would allow the setting of density/volume fractionation criteria for the generation of highly enriched populations of clonogenic cells from any tumour-cell suspension. The potential for this must, however, await a more extensive comparative study of density/volume parameters of clonogenic cells in different patients.
An extension of this study to the cellular differentiation of tumour cells (Mackillop & Buick, in press) should allow a more complete description of cellular organization in ovarian carcinoma, and monitoring post-therapeutic changes in the distribution of cells within these separated subpopulations may provide clues as to mechanisms and effectiveness of therapy. Although this study has been confined to a cell line and ascites cells from 2 human ovarian carcinomas, the methods described, when combined with adequate cell disaggregation and preparative procedures to remove normal cell populations, may be applicable to cell suspensions from solid tumours.
